Cutler Group LP Seelos Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 Apr 14, 2022	SELL	$0.84 - $1.71 $588 - $1,197	-700 Reduced 70.0%	300 $0
Q4 2021 Jan 18, 2022	SELL	$1.59 - $2.38 $4,134 - $6,188	-2,600 Reduced 72.22%	1,000 $1,000
Q3 2021 Oct 26, 2021	SELL	$1.69 - $2.89 $2,366 - $4,046	-1,400 Reduced 28.0%	3,600 $2,000
Q2 2021 Jul 19, 2021	BUY	$2.64 - $6.32 $1,584 - $3,792	600 Added 13.64%	5,000 $1,000
Q1 2021 Apr 26, 2021	BUY	$1.35 - $4.99 $5,940 - $21,956	4,400 New	4,400 $4,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $312M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.